











































(ml) r = 0.947, n = 9, p=0.0001
Y = 0.770 X + 6.565
r = 0.877, n = 9, p=0.0019
Y = 0.764 X + 20.013
US
Higashino H SCCT 2006
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•HARP Harmonic Phase Imaging
•Osman NF, Kerwin WS, McVeigh ER, Prince JL. 
Cardiac motion tracking using CINE harmonic phase 
(HARP) magnetic resonance imaging. Magn Reson 















































k-t BLAST (k-space and time (k-t) broad-use 








Log hazard ratio for revascularization vs. medical therapy (medical Rx) as a function of the percentage myocar- dium 
ischemic on the basis of final Cox proportional hazards model. Revasc 5 revascularization. *Model P , 0.0001; 
interaction P 5 0.0305.






























Kurata A. Circ J. 2005;69:550-7
12?2?3????
Hosokawa K. Circ J. 2011;75:1905-12
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TMPG transmural myocardial perfusion gradient





Systolic perfusion CT Diastolic CT
Myocardial ischemia
Nagao M. AJR Am J Roentgenol. 2008;191:19-25
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Myocardial blood flow
Kido T. Circ J 2008;72:1086-1091
MBF (ml/g/min)
Overall 1.83 ± 0.62
LAD 1.51 ± 0.65
LCX 2.11 ± 0.69
RCA 1.89 ± 0.38
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Myocardial blood flow




Log hazard ratio for revascularization vs. medical therapy (medical Rx) as a function of the percentage myocar- dium 
ischemic on the basis of final Cox proportional hazards model. Revasc 5 revascularization. *Model P , 0.0001; 
interaction P 5 0.0305.
























•?????? (??????25)  ? 8 ??
•??????? (?????40) ? 2.8 ??
•??????????? (????????) ? 2.3 ?
?





•?????? 1008 ± 21
•?????? 1080 ± 25.8
•????? (+)
•?????? 804 ± 25.2
•??????? 1022 ± 33.7
12?2?3????
?????
•n=271 (2011-09-17 - 2012-01-30)
•?? (?) 64 ± 11.6   ?/? 122 / 149
•BMI 24.1 ± 3.7   eGFR 71.6 ± 17.1
•HT 144, HL 127, DM 54, smoking 19, FH 2
•HR (bpm)
•?????? 75 ± 1.4

























Log hazard ratio for revascularization vs. medical therapy (medical Rx) as a function of the percentage myocar- dium 
ischemic on the basis of final Cox proportional hazards model. Revasc 5 revascularization. *Model P , 0.0001; 
interaction P 5 0.0305.











Log hazard ratio for revascularization vs. medical therapy (medical Rx) as a function of the percentage myocar- dium 
ischemic on the basis of final Cox proportional hazards model. Revasc 5 revascularization. *Model P , 0.0001; 
interaction P 5 0.0305.
Hachamovitch R et al. Circulation. 2003;107:2900–2907
CAG ---> MPI ---> PCI
12?2?3????
CAG ---> BMIPP ---> PCI
TL BMIPP ?????


















•???CT???? 60 ? 










































































































Event Rate of AMI and CD

























 Rates of cardiac death (solid bars) and myocardial infarction (open bars) per year as a function of scan 
result. The numbers of patients within each scan category are shown underneath each pair of columns. 
*Statistically significant increase as a function of scan result. **Statistically significant increase in rate of 









Score 0 > 80 %
Score 1 66 - 80 %
Score 2 50 - 65 %
Score 3 35 - 49 %







Methods: three color patterns
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Hot metal Rainbow P Rainbow T













SSS: summed stress score





Score0 Score1 Score2 Score3
Hot metal Rainbow P Rainbow T




































Higashino H. SNM 2010
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Initial score minus final score:







































TC patients 73 F
Hot metal Rainbow P Rainbow T
Score by PC software based on experts
Higashino H. SNM 2010
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TC patients 58 M
Hot metal Rainbow P Rainbow T
Score by PC software based on experts
























•Congratulations for considering CMR. It is a fantastic 
and rewarding field. But starting out can be daunting. 
CMR can be perceived as esoteric and complex. A 
major goal of SCMR is to people starting out in CMR. 
We would like you to join SCMR which you can do 
here. 
•In the meantime, here are some pointers.
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One stop shopping



















One stop shopping what you like









One stop shopping what you like




































































•300 - 400 HU
KIDO: keep fixed intensity of double opacities
??????
????
Cademartiri Eur Radiol 2005 15: 1426-31
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KIDO: keep fixed intensity of double opacities
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CCTA
ATP MPS
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MDCT CTA
68M OMI
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